Functional Medicine Blog

For years, estrogen products carried a black-box warning that shaped how women and clinicians approached menopause hormone therapy. The FDA’s recent decision to remove this warning is a major shift — one driven by updated research showing clearer benefits and a more favorable safety profile for many women. This article breaks down what changed, why it matters, and how this update is reshaping the conversation around hormone therapy.

Understanding Testosterone Therapy Testosterone therapy is commonly used to treat low testosterone (low T) levels  in men, helping...